Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Takes PCR License from Roche for In Vitro Diagnostics

NEW YORK, June 24 (GenomeWeb News) - Cepheid has licensed several PCR-related patents from Roche for in vitro diagnostic products, the Sunnyvale, Calif.-based company said today.


The non-exclusive license comprises Roche patents covering the PCR process, reverse transcription-based methods, nucleic acid quantification methods, real-time PCR detection, and methods for the detection of viral and cancer targets.


Cepheid is permitted to make, use, and sell products based on these technologies for in vitro human diagnostics, except for human identify testing and pathogen detection for blood bank screening and plasma fractionation. Cepheid will pay Roche a licensing fee and ongoing royalties on sales of relevant products.


Yesterday, Cepheid said it has expanded its license to Applera's PCR patents to include real-time PCR.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.